The Two-Phase MARPE Protocol:
Sequential Suture Disarticulation
and Slow Activation for High-Resistance Adults
Master the staged approach to palatal expansion in mature patients. Learn when disarticulation precedes loading, how suture maturity predicts success, and activation schedules for maximal skeletal gain.
TL;DR The two-phase MARPE protocol uses sequential suture disarticulation in phase one to soften midpalatal resistance, followed by controlled slow activation in phase two for predictable skeletal expansion in adults. This staged approach reduces relapse risk and improves outcomes in cases with mature, densified palatal sutures resistant to conventional rapid loading.
High-resistance palatal sutures in mature adults remain a significant clinical barrier to non-surgical skeletal expansion. The two-phase MARPE protocol addresses this challenge through sequential suture disarticulation followed by slow activation, a staged approach that has gained traction in contemporary clinical practice over the past five years. Dr. Mark Radzhabov and other leading researchers have documented how this method achieves true skeletal widening in adults previously considered poor candidates for palatal expansion. This guide reviews the biomechanical rationale, activation schedules, radiographic staging criteria, and patient selection framework essential for implementing this technique in your practice.
Understanding the Two-Phase MARPE:
Why Sequential Disarticulation Works
The two-phase MARPE protocol distinguishes itself from conventional single-activation approaches by inserting a preparatory disarticulation phase before therapeutic expansion. In phase one (weeks 1–4), the appliance is activated at 0.25 mm per week—a rate slow enough to initiate sutural separation without generating excessive palatal stress. During this period, the midpalatal suture undergoes progressive resorption of its dense calcified matrix, particularly in the anterior region where fusion typically completes first. Phase two begins only after radiographic confirmation of sutural softening, then accelerates to 0.5–1.0 mm per week to drive true skeletal expansion while the suture remains resorptive.
This staggered approach directly addresses the biomechanical reality of mature palatal anatomy: a 50-year-old's midpalatal suture is not simply a wider version of a 12-year-old's—it contains significant cortical bone layering, reduced vascularity, and calcified interstitial gaps. Attempting rapid expansion in this environment triggers dental tipping, relapse, and incomplete skeletal response. Sequential disarticulation allows osteoclastic remodeling to precede mechanical loading, fundamentally altering the tissue's capacity to accept force.
Orthodontist Mark's clinical cohort (unpublished, 2023–2025) tracked 34 adults over age 45 using the two-phase protocol and achieved 7.2 mm average skeletal widening compared to 4.1 mm in age-matched controls using single-phase MARPE. Relapse at 12 months post-retention was 0.8 mm versus 2.3 mm in the control group. These figures underscore that phase sequencing is not merely theoretical—it produces measurable differences in stability and magnitude.
Cone-Beam CT Assessment of Palatal Suture
Maturity and Protocol Selection
Selecting the two-phase MARPE over conventional RPE or single-phase MARPE hinges on accurate radiographic classification of midpalatal suture maturation. The Angelieri staging system (introduced 2016) categorizes the suture from stage A (completely radiolucent, fully open) to stage D (completely ossified with no separation visible). Patients in stage B (radiolucent with white horizontal striae indicating early calcification) are ideal candidates for two-phase activation: they have sufficient residual suture space to respond to disarticulation loading, yet enough calcification to warrant the slower, gentler approach.
Stage C patients (mostly calcified with scattered radiolucent areas) represent the highest-resistance cohort and benefit most from the two-phase design. A 52-year-old presenting with stage C anatomy should not be moved immediately into aggressive activation. Instead, the 4-week disarticulation phase allows the scattered radiolucent zones to enlarge and resorption to propagate. Clinical experience suggests that without this preparatory phase, stage C cases often plateau after 4–5 mm of expansion, with subsequent loading producing only dental compensation.
Stage D (complete ossification) typically requires surgical intervention—SARPE—because miniscrew-assisted approaches alone cannot generate sufficient biological resorption. However, patients in the stage B–C transition benefit significantly from the two-phase protocol, which maximizes the window for non-surgical skeletal response. CBCT imaging with Hounsfield unit densitometry (HU values >600 in the anterior suture region indicate advanced mineralization) provides quantitative confirmation of suture resistance and helps clinicians distinguish those capable of disarticulation-responsive remodeling from those requiring surgical sectioning.
Phase One and Phase Two Activation
Schedules for High-Resistance Adults
The activation schedule is the operational heart of the two-phase protocol. Week 1 begins with the appliance installed and tightened to deliver initial intrusive force of 50–75 cN per side (measured at miniscrew-to-arm coupling). Activations occur every 7 days, advancing 0.25 mm per week for the first four weeks. This ultra-slow initial rate is critical: rapid advancement in a stage C suture overwhelms the resorptive capacity of the tissue, forcing the palate to respond through dentoalveolar tipping rather than true sutural separation. By week 3, cone-beam CT or periapical radiographs (using a standardized occlusal index) confirm progressive widening at the anterior palate and initial radiolucency expansion at the suture midline.
Phase two begins in week 5 (or week 6 in very dense cases) once radiographic evidence of disarticulation is confirmed. Force increases to 0.5 mm per week for weeks 5–8, then 1.0 mm per week for weeks 9 onward, pending patient comfort and absence of excessive dental tipping. This staged acceleration allows the suture—now in an active resorptive state—to accept greater mechanical demand. Total treatment duration to achieve 6–8 mm of expansion typically spans 12–16 weeks; a single-phase protocol might accomplish the same distance in 8–10 weeks but with significantly higher relapse and dental side effects.
Miniscrew diameter, insertion angle, and palatal location directly affect load distribution. Grade 5 titanium miniscrews (1.4–1.6 mm diameter, 6 mm insertion depth into cortical bone) inserted perpendicular to the hard palate at the mesial-distal midline and anterior-posterior midpoint ensure balanced force transmission across both left and right hemi-palate regions. Asymmetric insertion (e.g., too far buccal on one side) creates shearing at the suture and reduces skeletal response. Orthodontist Mark emphasizes that palatal anatomy varies, and preoperative CBCT with measurement-confirmed insertion sites prevents this error.
When the Suture Resists:
Plateau Detection and Protocol Modification
Even with careful staging, some stage C patients fail to achieve the expected 6–8 mm of skeletal expansion and plateau at 3–5 mm by week 8–10. Plateau occurs when the suture's resorptive capacity cannot keep pace with mechanical loading—a sign that the tissue is either denser than preoperative imaging suggested or that the miniscrew anchorage has shifted. Serial CBCT imaging at weeks 4, 8, and 12 reveals whether widening is occurring at the anterior, middle, and posterior suture regions uniformly or whether anterior separation is progressing while middle and posterior regions remain fused. Asymmetric expansion predicts that continued loading will produce excessive tipping and spiral-groove widening rather than pure skeletal gain.
Response protocol for plateau: Reduce activation frequency to every 10–14 days and maintain current inter-miniscrew distance for 3–4 additional weeks, allowing biological response to catch up. Do not advance beyond 0.75 mm/week in plateau scenarios. Paradoxically, reducing load intensity often restarts expansion by permitting the suture to resorb without mechanical obstruction. If plateau persists beyond week 12, consider intravenous bisphosphonate consultation (evidence is preliminary but suggests reduced osteoclast activity may impair disarticulation) or surgical SARPE to complete the expansion. Serial radiographs documenting stalled widening provide medico-legal protection and inform the patient that biology, not technique failure, is the limiting factor.
Relapse risk escalates if the suture is forced open beyond its resorptive timeline. A case that achieves only 4 mm of true skeletal gain over 12 weeks will likely lose 1.5–2.0 mm of that gain in the first 6 months post-retention because the suture, incompletely disarticulated, re-ossifies around the new width. In contrast, cases that achieve the full 6–8 mm through proper two-phase sequencing show relapse of only 0.5–1.0 mm, reflecting a fundamentally different biological state. This difference—between forcing incompletely disarticulated bone versus maintaining expansion within a resorptive environment—is why the two-phase protocol's pace cannot be shortened without consequence.
Post-Expansion Retention:
Timing and Appliance Strategy
Retention protocol directly affects the clinical longevity of two-phase MARPE expansion. Unlike single-phase rapid expansion, which generates some immediate sutural fusion through intensive mechanical stress, two-phase disarticulation leaves the suture in an actively resorptive state at the conclusion of loading. The newly widened suture contains low-density callus bone and incomplete re-mineralization. Removing the miniscrew immediately after week 12 or 16 initiates rapid re-ossification within the expanded space, culminating in significant relapse by month 6. Best practice involves maintaining miniscrew anchorage in place for 4–6 months post-expansion, during which the suture gradually re-mineralizes under stable conditions. This extended retention phase allows osteoblasts to deposit mature lamellar bone at the sutural margin, converting labile callus into mechanically stable structure.
Concurrent use of a palatal expansion retainer (rigid acrylic or bonded wire) augments miniscrew retention and constrains any early dentoalveolar relapse. The retainer should maintain the expanded width without applying new force. It functions as a passive stabilizer. After miniscrew removal at the 4–6 month mark, the bonded or cemented retainer remains in place for 12–24 months. Clinical data show that two-phase expansion combined with extended miniscrew retention and retainer wear exhibits only 0.8–1.2 mm of relapse at 12 months compared to 2.0–3.5 mm in single-phase or unsupported expansion.
Patient adherence to retention is often overlooked in discussions of expansion protocol, yet it determines whether the months of disarticulation and activation yield permanent skeletal benefit. Clearly communicating to the patient that the appliance remains for 4–6 months post-expansion (not the typical 8–10 months) and that night-time retainer wear continues into year two sets realistic expectations. A 45-year-old expanding the palate should understand that their tissue remodels more slowly than a teenager's. Respecting that biology prevents the disappointment of seeing months of expansion reversed by poor retention practices.
Defining the Ideal Candidate for Two-Phase
MARPE in High-Resistance Cases
Patient selection for the two-phase MARPE protocol begins with radiographic staging and extends to medical history, skeletal growth status, and patient motivation. Candidates should be skeletally mature (aged 25+) with stage B or stage C midpalatal suture anatomy and transverse maxillary deficiency of 6–10 mm that cannot be corrected through dental repositioning alone. Age above 50 is not a contraindication. Some of the most dramatic and stable skeletal responses occur in patients aged 50–65, provided suture staging confirms sufficient radiolucency to permit disarticulation. Conversely, a 28-year-old in stage A (fully open suture) is a poor candidate because conventional single-phase rapid expansion or even tooth-borne RPE will succeed with far less time and complexity.
Medical screening should exclude uncontrolled hypertension, bleeding disorders, and active periodontal disease. Bisphosphonate therapy (for osteoporosis) is a relative contraindication because bisphosphonates suppress osteoclast activity and may impair sutural resorption during the disarticulation phase. These patients warrant consultation with their physician and possible washout period before MARPE initiation. Psychosocial factors matter: the patient must be willing to maintain 4–6 month miniscrew retention, attend monthly or bi-weekly activation and monitoring appointments, and comply with retention wear afterward. A motivated 52-year-old with stage C suture anatomy and 8 mm transverse deficiency is an excellent candidate. An anxious 45-year-old with mild crowding and stage B suture who wants instant results is not.
Incisor inclination and buccal alveolar bone thickness should be assessed preoperatively. Thick buccal cortices (>4 mm) and normal to slightly proclined incisors tolerate the dental tipping that inevitably occurs despite bone-borne anchorage. Conversely, thin alveolar biotype and retroclined incisors are at risk for dehiscence if expansion creates excessive buccal expansion. In these instances, the slow-activation feature of the two-phase protocol becomes even more valuable: lower forces reduce dentoalveolar stress and minimize tipping. Orthodontist Mark's case selection emphasizes that skeletal expansion without adequate dentoalveolar margin for movement is a setup for periodontally compromised outcomes.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
How does the two-phase MARPE protocol differ from single-phase MARPE in managing high-resistance sutures?
Phase one uses 0.25 mm/week disarticulation to initiate sutural resorption without mechanical overload. Phase two follows with 0.5–1.0 mm/week expansion once the suture is resorptive. Single-phase uses faster loading from the start, causing higher relapse and dentoalveolar tipping in resistant stage B–C sutures.
What is the optimal miniscrew diameter and insertion depth for two-phase MARPE?
Grade 5 titanium miniscrews, 1.4–1.6 mm diameter, inserted perpendicular to hard palate at the mesial-distal and anterior-posterior midpoints, with 6 mm cortical bone insertion. Perpendicular placement ensures balanced bilateral force and prevents shearing at the suture.
How long does the disarticulation phase typically last before transitioning to phase two activation?
Weeks 1–4 of phase one (typically 4 weeks at 0.25 mm/week) followed by radiographic confirmation of sutural softening via CBCT. In very dense stage C cases, disarticulation may extend to week 5–6 before accelerating to 0.5 mm/week in phase two.
What radiographic findings indicate readiness to transition from phase one to phase two?
CBCT at week 3–4 should show progressive radiolucency widening at the anterior suture midline, separation of cortical borders, and expansion of scattered calcified zones. Anterior widening >1 mm with visible resorption margins confirms suture disarticulation and readiness for accelerated loading.
How do I detect and manage plateau (stalled expansion) in two-phase MARPE cases?
Serial CBCT at weeks 8 and 12 reveals stalled inter-miniscrew distance despite compliant activation. Response: reduce frequency to 10–14 day intervals, maintain 0.5 mm/week (do not increase to 1.0 mm), and allow 3–4 weeks biological catch-up. If plateau persists, consider SARPE.
What is the miniscrew retention duration after achieving target expansion?
Maintain miniscrews in place for 4–6 months post-expansion to allow sutural re-mineralization under stable conditions. Concurrent bonded palatal retainer prevents dentoalveolar relapse. This extended retention reduces 12-month relapse to 0.8–1.2 mm versus 2.0–3.5 mm without support.
Which patient age groups benefit most from two-phase MARPE for resistant sutures?
Patients aged 35–65 with stage B–C suture anatomy show optimal response. Age alone is not a contraindication. A 60-year-old in stage C may achieve 7–8 mm skeletal expansion with proper disarticulation protocol, whereas a 28-year-old in stage A will relapse significantly.
How does alveolar bone thickness affect two-phase MARPE candidacy and outcome?
Thick buccal cortex (>3 mm) tolerates the unavoidable dentoalveolar tipping that occurs despite bone-borne anchorage. Thin biotype (<2 mm) carries dehiscence risk. These patients may require slower loading (maintain phase two at 0.5 mm/week) or alternative treatment, such as surgical expansion.
What medical conditions contraindicate or complicate two-phase MARPE?
Bisphosphonate therapy (osteoclast suppression) may impair sutural resorption during phase one. Active periodontal disease and uncontrolled hypertension are relative contraindications. Consult with the patient's physician regarding bisphosphonate washout before MARPE initiation in osteoporosis cases.
Can two-phase MARPE avoid the need for surgical SARPE in stage C or stage D cases?
Stage B–C cases respond well to two-phase MARPE and avoid surgery. Stage D (complete ossification) typically requires SARPE because miniscrew-assisted approaches cannot generate sufficient disarticulation resorption. Careful CBCT staging and HU densitometry distinguish candidates before treatment initiation.
The two-phase MARPE protocol represents a paradigm shift in managing transverse deficiency in skeletally mature adults, replacing the false choice between tooth-borne expansion and surgery. By staging activation and respecting suture maturity, clinicians can achieve 6–8 mm of true skeletal gain with lower relapse rates than conventional single-phase protocols. Dr. Mark Radzhabov's evidence-based framework for sequential disarticulation provides a reproducible roadmap for complex adult cases. For case consultation or deeper training in protocol optimization, visit ortodontmark.com or schedule a clinical review of your high-resistance cases.
